Current Assets
Prepaid & Other Current
Regeneron Pharmaceuticals Prepaid & Other Current increased by 30.8% to $620.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.4%, from $468.90M to $620.90M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 24.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
How to read this metric
Significant fluctuations may indicate changes in corporate procurement cycles or shifts in accounting for short-term financial instruments.
Detailed definition
Payments made in advance for services or goods to be received within the next year, alongside other miscellaneous short-...
Peer comparison
Generally a small percentage of current assets; large spikes may warrant investigation into non-recurring items.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $444.30M | $482.00M | $332.40M | $424.90M | $583.60M | $446.40M | $411.20M | $406.20M | $366.30M | $574.70M | $386.60M | $414.90M | $681.90M | $412.00M | $349.20M | $468.90M | $574.30M | $595.60M | $474.80M | $620.90M |
| QoQ Change | — | +8.5% | -31.0% | +27.8% | +37.3% | -23.5% | -7.9% | -1.2% | -9.8% | +56.9% | -32.7% | +7.3% | +64.4% | -39.6% | -15.2% | +34.3% | +22.5% | +3.7% | -20.3% | +30.8% |
| YoY Change | — | — | — | — | +31.4% | -7.4% | +23.7% | -4.4% | -37.2% | +28.7% | -6.0% | +2.1% | +86.2% | -28.3% | -9.7% | +13.0% | -15.8% | +44.6% | +36.0% | +32.4% |
Range$332.40M – $681.90M
CAGR+7.3%
Avg YoY Growth+11.8%
Median YoY Growth+7.6%
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's prepaid & other current?
- Regeneron Pharmaceuticals (REGN) reported prepaid & other current of $620.90M in Q1 2026.
- How has Regeneron Pharmaceuticals's prepaid & other current changed year-over-year?
- Regeneron Pharmaceuticals's prepaid & other current increased by 32.4% year-over-year, from $468.90M to $620.90M.
- What is the long-term trend for Regeneron Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's prepaid & other current has grown at a 24.2% compound annual growth rate (CAGR), from $160.80M to $474.80M.
- What does prepaid & other current mean?
- Assets representing payments made for future services or miscellaneous short-term holdings.